First introduced as a treatment for Type 2 diabetes and now pursued as a blockbuster weight management therapy, GLP-1 receptor agonists (GLP-1 RAs) have ignited a global scale-up effort that is reshaping the drug manufacturing landscape.
Read MoreJames Golden
Fellow – Chemical Process
Kansas City, MO
James Golden brings over 23 years of experience in pharmaceutical engineering and is a licensed Professional Engineer in multiple states. His expertise spans a wide range of areas, with a strong focus on oral solid dose (OSD) manufacturing, powder handling, high-hazard containment, and the design of facilities handling hazardous chemicals, oligonucleotides, and peptides.
As a Fellow at CRB, James serves as co-lead of the firm’s Hazardous Material Community of Practice. In this role, he plays a key part in advancing internal knowledge and best practices related to safety and facility design for hazardous materials—contributing to the success of future projects in rapidly evolving sectors such as peptides and oligonucleotides.
James is a long-standing member of the International Society for Pharmaceutical Engineering (ISPE). He has served on the API Community of Practice Committee and is currently a contributing author for the upcoming ISPE Baseline Guide on Peptide and Oligonucleotide Facility Design.
“As a professional engineer, I blend pragmatism with technical competency to tackle complex challenges in hazardous environments. My work demands not only a keen understanding of chemical processes but also the ability to anticipate risks and implement solutions that ensure safety and efficiency. Collaboration is key—I engage with multidisciplinary teams to refine processes, optimize performance, and uphold rigorous standards. By combining practical decision-making with expertise, I contribute to operations that are both resilient and effective.”